NCT02839226View on ClinicalTrials.gov

Safety and Efficacy of Topical AR/101 Compared With Placebo, in Accelerating Granulation Tissue Formation of Hard-to-heal Wounds

PHASE2UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
WoundsOther Ulcers Wounds and Skin Problems
Interventions
DRUG

AR/101

DRUG

Placebo

Trial Locations (1)

96105

Sourasky Medical Center, Tel Aviv

Sponsors
All Listed Sponsors
lead

Arava Bio Tech Ltd.

INDUSTRY